Stromal cell-derived factor-1 from biliary epithelial cells recruits CXCR4-positive cells: Implications for inflammatory liver diseases

Laboratory Investigation

Volumn 83, Issue 5, 2003, Pages 665-672

  Terada, Ryo ^a   Yamamoto, Kazuhide ^a   Hakoda, Tomomi ^a   Shimada, Noriaki ^a   Okano, Nobuaki ^a   Baba, Nobuyuki ^a   Ninomiya, Yoshifumi ^a   Gershwin, M Eric ^b   Shiratori, Yasushi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; AUTOIMMUNE HEPATITIS; CONTROLLED STUDY; EPITHELIUM CELL; FLOW CYTOMETRY; HEMATOPOIESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS HEPATITIS;

EID: 0038137351     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.LAB.0000067498.89585.06     Document Type: Article

References (44)

1. Afford SC, Ahmed-Choudhury J, Randhawa S, Russell C, Youster J, Crosby HA, Eliopoulos A, Hubscher SG, Young LS, and Adams DH (2001). CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB/AP-1 signaling in human intrahepatic biliary epithelial cells. FASEB J 15:2345-2354.
2. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, and Springer TA (1996). The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382:829-833.
3. Buckley CD, Amft N, Bradfield PF, Pilling D, Ross E, Arenzana-Seisdedos F, Amara A, Curnow SJ, Lord JM, Scheel-Toellner D, and Salmon M (2000). Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium. J Immunol 165:3423-3429.
4. Coulomb-L'Hermin A, Amara A, Schiff C, Durand-Gasselin I, Foussat A, Delaunay T, Chaouat G, Capron F, Ledee N, Galanaud P, Arenzana-Seisdedos F, and Emilie D (1999). Stromal cell-derived factor 1 (SDF-1) and antenatal human B cell lymphopoiesis: Expression of SDF-1 by mesothelial cells and biliary ductal plate epithelial cells. Proc Natl Acad Sci USA 96:8585-8590.
5. Cruickshank SM, Southgate J, Selby PJ, and Trejdosiewicz LK (1998). Expression and cytokine regulation of immune recognition elements by normal human biliary epithelial and established liver cell lines in vitro. J Hepatol 29:550-558.
6. Cyster JG (1999). Chemokines and cell migration in secondary lymphoid organs. Science 286:2098-2102.
7. Czaja AJ and Carpenter HA (2001). Autoimmune hepatitis with incidental histologic features of bile duct injury. Hepatology 34:659-665.
8. Fedyk ER, Jones D, Critchley HO, Phipps RP, Blieden TM, and Springer TA (2001). Expression of stromal-derived factor-1 is decreased by IL-1 and TNF and in dermal wound healing. J Immunol 166:5749-5754.
9. Goddard S, Williams A, Morland C, Qin S, Gladue R, Hubscher SG, and Adams DH (2001). Differential expression of chemokines and chemokine receptors shapes the inflammatory response in rejecting human liver transplants. Transplantation 72:1957-1967.
10. Grant AJ, Goddard S, Ahmed-Choudhury J, Reynolds G, Jackson DG, Briskin M, Wu L, Hubscher SG, and Adams DH (2002). Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease. Am J Pathol 160:1445-1455.
11. Hirano F, Kobayashi A, Hirano Y, Nomura Y, Fukawa E, and Makino I (2001). Bile acids regulate RANTES gene expression through its cognate NF-kappaB binding sites. Biochem Biophys Res Commun 288:1095-1101.
12. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN, et al (1995). Histological grading and staging of chronic hepatitis. J Hepatol 22:696-699.
13. Kaji K, Nakanuma Y, Sasaki M, Unoura M, Kobayashi K, Nonomura A, Tsuneyama K, Van de Water J, and Gershwin ME (1994). Hepatitic bile duct injuries in chronic hepatitis C: Histopathologic and immunohistochemical studies. Mod Pathol 7:937-945.
14. Kim CH and Broxmeyer HE (1999). Chemokines: Signal lamps for trafficking of T and B cells for development and effector function. J Leukoc Biol 65:6-15.
15. Kusano F, Tanaka Y, Marumo F, and Sato C (2000). Expression of C-C chemokines is associated with portal and periportal inflammation in the liver of patients with chronic hepatitis C. Lab Invest 80:415-422.
16. Ludwig J, Czaja AJ, Dickson ER, LaRusso NF, and Wiesner RH (1984). Manifestations of nonsuppurative cholangitis in chronic hepatobiliary diseases: Morphologic spectrum, clinical correlations and terminology. Liver 4:105-116.
17. Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, Bronson RT, and Springer TA (1998). Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci USA 95:9448-9453.
18. Ma Q, Jones D, and Springer TA (1999). The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity 10:463-471.
19. Marra F, DeFranco R, Grappone C, Milani S, Pastacaldi S, Pinzani M, Romanelli RG, Laffi G, and Gentilini P (1998). Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: Correlation with monocyte infiltration. Am J Pathol 152:423-430.
20. Melchers F, Rolink AG, and Schaniel C (1999). The role of chemokines in regulating cell migration during humoral immune responses. Cell 99:351-354.
21. + hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood 91:4523-4530.
22. Mosnier JF, Scoazec JY, Marcellin P, Degott C, Benhamou JP, and Feldmann G (1994). Expression of cytokine-dependent immune adhesion molecules by hepatocytes and bile duct cells in chronic hepatitis C. Gastroenterology 107:1457-1468.
23. Nagasawa T (2000). A chemokine, SDF-1/PBSF, and its receptor, CXC chemokine receptor 4, as mediators of hematopoiesis. Int J Hematol 72:408-411.
24. Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, Yoshida N, Kikutani H, and Kishimoto T (1996). Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382:635-638.
25. Nakanuma Y (1993). Distribution of B lymphocytes in nonsuppurative cholangitis in primary biliary cirrhosis. Hepatology 18:570-575.
26. + T cell accumulation in rheumatoid arthritis synovium. J Immunol 165:6590-6598.
27. + T cell activation. J Immunol 164:5010-5014.
28. Narumi S, Tominaga Y, Tamaru M, Shimai S, Okumura H, Nishioji K, Itoh Y, and Okanoue T (1997). Expression of IFN-inducible protein-10 in chronic hepatitis. J Immunol 158:5536-5544.
29. Nishioji K, Okanoue T, Itoh Y, Narumi S, Sakamoto M, Nakamura H, Morita A, and Kashima K (2001). Increase of chemokine interferon-inducible protein-10 (IP-10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes. Clin Exp Immunol 123:271-279.
30. Pablos JL, Amara A, Bouloc A, Santiago B, Caruz A, Galindo M, Delaunay T, Virelizier JL, and Arenzana-Seisdedos F (1999). Stromal-cell derived factor is expressed by dendritic cells and endothelium in human skin. Am J Pathol 155:1577-1586.
31. Poznansky MC, Olszak IT, Foxall R, Evans RH, Luster AD, and Scadden DT (2000). Active movement of T cells away from a chemokine. Nat Med 6:543-548.
32. Sallusto F, Lanzavecchia A, and Mackay CR (1998). Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 19:568-574.
33. Scheuer P (1967). Primary biliary cirrhosis. Proc R Soc Med 60:1257-1260.
34. Shields PL, Morland CM, Salmon M, Qin S, Hubscher SG, and Adams DH (1999). Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunol 163:6236-6243.
35. Shimizu Y, Murata H, Kashii Y, Hirano K, Kunitani H, Higuchi K, and Watanabe A (2001). CC-chemokine receptor 6 and its ligand macrophage inflammatory protein 3alpha might be involved in the amplification of local necroinflammatory response in the liver. Hepatology 34:311-319.
36. Shirozu M, Nakano T, Inazawa J, Tashiro K, Tada H, Shinohara T, and Honjo T (1995). Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics 28:495-500.
37. Tamaru M, Nishioji K, Kobayashi Y, Watanabe Y, Itoh Y, Okanoue T, Murai M, Matsushima K, and Narumi S (2000). Liver-infiltrating T lymphocytes are attracted selectively by IFN-inducible protein-10. Cytokine 12:299-308.
38. Tsuneyama K, Harada K, Yasoshima M, Hiramatsu K, Mackay CR, Mackay IR, Gershwin ME, and Nakanuma Y (2001). Monocyte chemotactic protein-1, -2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: Implications for pathogenesis. J Pathol 193:102-109.
39. + cells is related to hematopoietic recovery after autologous stem cell transplantation. Blood 97:799-804.
40. von Andrian UH and Mackay CR (2000). T-cell function and migration: Two sides of the same coin. N Engl J Med 343:1020-1034.
41. Westermann J, Engelhardt B, and Hoffmann JC (2001). Migration of T cells in vivo: Molecular mechanisms and clinical implications. Ann Intern Med 135:279-295.
42. Yabushita K, Yamamoto K, Ibuki N, Okano N, Matsumura S, Okamoto R, Shimada N, and Tsuji T (2001). Aberrant expression of cytokeratin 7 as a histological marker of progression in primary biliary cirrhosis. Liver 21:50-55.
43. Yasoshima M, Nakanuma Y, Tsuneyama K, Van de Water J, and Gershwin ME (1995). Immunohistochemical analysis of adhesion molecules in the micro-environment of portal tracts in relation to aberrant expression of PDC-E2 and HLA-DR on the bile ducts in primary biliary cirrhosis. J Pathol 175:319-325.
44. Yoneyama H, Matsuno K, Zhang Y, Murai M, Itakura M, Ishikawa S, Hasegawa G, Naito M, Asakura H, and Matsushima K (2001). Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tractassociated lymphoid tissue, in a granulomatous liver disease. J Exp Med 193:35-49.